drugset / Trial / NCT02497365
Besifloxacin in Bacterial Keratitis
Completed
32 enrolled
McGill University Health Centre/Research Institute of the McGill University Health Centre
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a study comparing a new treatment for bacterial keratitis (also known as corneal ulcers) with the current standard of care. It is a randomized trial, and the investigators plan to test whether besifloxacin (a new antibiotic) in comparison to the current standard of treatment, fortified antibiotic drops (cefazolin and tobramycin).
Timeline
- Start
- 2015-09
- Primary completion
- 2019-06
- Completion
- 2019-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Besifloxacin | Small molecule | 0.6 % | — |
| Comparator | Cefazolin | Small molecule | — | Topical |
| Comparator | Tobramycin | Small molecule | — | Topical |